XML 47 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Cash flows from operating activities:      
Net loss $ (8,475)us-gaap_NetIncomeLoss $ (11,275)us-gaap_NetIncomeLoss $ (17,598)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Gain on sale of real estate, net (1,846)us-gaap_GainLossOnSaleOfProperties 0us-gaap_GainLossOnSaleOfProperties 0us-gaap_GainLossOnSaleOfProperties
Gain on sale of subsidiaries, net of adjustments (739)us-gaap_GainLossOnSaleOfOtherAssets (3,430)us-gaap_GainLossOnSaleOfOtherAssets (65)us-gaap_GainLossOnSaleOfOtherAssets
Depreciation and amortization 1,220us-gaap_Depreciation 2,200us-gaap_Depreciation 4,191us-gaap_Depreciation
Amortization of deferred financing fees 343us-gaap_AmortizationOfFinancingCosts 298us-gaap_AmortizationOfFinancingCosts 136us-gaap_AmortizationOfFinancingCosts
Provision for bad debt expense 85us-gaap_ProvisionForDoubtfulAccounts (380)us-gaap_ProvisionForDoubtfulAccounts 207us-gaap_ProvisionForDoubtfulAccounts
Share-based compensation expense 503us-gaap_ShareBasedCompensation 643us-gaap_ShareBasedCompensation 710us-gaap_ShareBasedCompensation
Impairment of long-lived assets, loss on disposal of fixed assets and other 181hh_ImpairmentOfLongLivedAssetsAndGainLossOnDisposalOfFixedAssets 416hh_ImpairmentOfLongLivedAssetsAndGainLossOnDisposalOfFixedAssets 5,310hh_ImpairmentOfLongLivedAssetsAndGainLossOnDisposalOfFixedAssets
Change in assets and liabilities:      
Accounts receivable 5,135us-gaap_IncreaseDecreaseInAccountsReceivable 9,000us-gaap_IncreaseDecreaseInAccountsReceivable 1,161us-gaap_IncreaseDecreaseInAccountsReceivable
Inventories (300)us-gaap_IncreaseDecreaseInInventories (62)us-gaap_IncreaseDecreaseInInventories (5)us-gaap_IncreaseDecreaseInInventories
Other assets 1,005us-gaap_IncreaseDecreaseInOtherOperatingAssets (184)us-gaap_IncreaseDecreaseInOtherOperatingAssets 1,334us-gaap_IncreaseDecreaseInOtherOperatingAssets
Accounts payable, accrued expenses and other liabilities (542)us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities (4,255)us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities 442us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
Net cash used in operating activities (3,430)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (7,029)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (4,177)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities:      
Capital expenditures (1,409)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (1,550)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (4,103)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Proceeds from sale of real estate, net of closing costs 2,544us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment 0us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment 0us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment
Proceeds from the sale of Heritage Labs and Hooper Holmes Services 3,539hh_ProceedsfromDivestitureofBusinesses2 0hh_ProceedsfromDivestitureofBusinesses2 0hh_ProceedsfromDivestitureofBusinesses2
Cost paid to sell Heritage Labs and Hooper Holmes Services (777)hh_PaymentsforDivestitureofBusinesses 0hh_PaymentsforDivestitureofBusinesses 0hh_PaymentsforDivestitureofBusinesses
Proceeds from the sale of Portamedic 743us-gaap_ProceedsFromDivestitureOfBusinesses 6,053us-gaap_ProceedsFromDivestitureOfBusinesses 0us-gaap_ProceedsFromDivestitureOfBusinesses
Costs paid to sell Portamedic 0hh_DisposalGroupIncludingDiscontinuedOperationTransactionCosts1 (781)hh_DisposalGroupIncludingDiscontinuedOperationTransactionCosts1 0hh_DisposalGroupIncludingDiscontinuedOperationTransactionCosts1
Proceeds from sale of fixed assets 0us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment 0us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment 51us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment
Net cash provided by (used in) investing activities 4,640us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations 3,722us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (4,052)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash flows from financing activities:      
Borrowings under credit facility 0us-gaap_ProceedsFromLongTermLinesOfCredit 50,827us-gaap_ProceedsFromLongTermLinesOfCredit 0us-gaap_ProceedsFromLongTermLinesOfCredit
Payments under credit facility 0us-gaap_RepaymentsOfLongTermLinesOfCredit (50,827)us-gaap_RepaymentsOfLongTermLinesOfCredit 0us-gaap_RepaymentsOfLongTermLinesOfCredit
Debt financing fees 0us-gaap_PaymentsOfFinancingCosts (999)us-gaap_PaymentsOfFinancingCosts (101)us-gaap_PaymentsOfFinancingCosts
Proceeds related to the exercise of stock options 29us-gaap_ProceedsFromStockOptionsExercised 71us-gaap_ProceedsFromStockOptionsExercised 0us-gaap_ProceedsFromStockOptionsExercised
Payments on capital lease obligations (8)us-gaap_RepaymentsOfLongTermCapitalLeaseObligations (114)us-gaap_RepaymentsOfLongTermCapitalLeaseObligations (268)us-gaap_RepaymentsOfLongTermCapitalLeaseObligations
Net cash used in financing activities 21us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations (1,042)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations (369)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Net decrease in cash and cash equivalents 1,231us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (4,349)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (8,598)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents at beginning of year 3,970us-gaap_CashAndCashEquivalentsAtCarryingValue 8,319us-gaap_CashAndCashEquivalentsAtCarryingValue 16,917us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents at end of year 5,201us-gaap_CashAndCashEquivalentsAtCarryingValue 3,970us-gaap_CashAndCashEquivalentsAtCarryingValue 8,319us-gaap_CashAndCashEquivalentsAtCarryingValue
Supplemental disclosure of non-cash investing activities:      
Fixed assets vouchered but not paid 163us-gaap_CapitalExpendituresIncurredButNotYetPaid 153us-gaap_CapitalExpendituresIncurredButNotYetPaid 154us-gaap_CapitalExpendituresIncurredButNotYetPaid
Fixed assets acquired by capital leases 0us-gaap_CapitalLeaseObligationsIncurred 0us-gaap_CapitalLeaseObligationsIncurred 64us-gaap_CapitalLeaseObligationsIncurred
Proceeds from sale of Portamedic not received, net of costs not paid 0hh_NoncashorPartNoncashDivestitureAmountofConsiderationNotReceivedNetofCostsNotPaid 1,525hh_NoncashorPartNoncashDivestitureAmountofConsiderationNotReceivedNetofCostsNotPaid 0hh_NoncashorPartNoncashDivestitureAmountofConsiderationNotReceivedNetofCostsNotPaid
Supplemental disclosure of cash flow information:      
Cash paid during the period for income taxes $ 53us-gaap_IncomeTaxesPaid $ 62us-gaap_IncomeTaxesPaid $ 50us-gaap_IncomeTaxesPaid